Single framework recombinant antibody fragments designed for protein chip applications

BioTechniques

Volumn 33, Issue 6 SUPPL., 2002, Pages 38-45

  Steinhauer, Cornelia ^a   Wingren, Christer ^a   Malmborg Hager, Ann Christin ^a   Borrebaeck, Carl A K ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODIES; GENETIC ENGINEERING; PROTEINS;

MOLECULAR DESIGN;

BIOTECHNOLOGY;

RECOMBINANT ANTIBODY; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY; IMMUNOGLOBULIN FRAGMENT; MONOCLONAL ANTIBODY; PEPTIDE LIBRARY; PROTEIN; RECOMBINANT PROTEIN;

ADSORPTION; ANTIBODY LIBRARY; ANTIBODY MICROARRAY; ARTICLE; GENOME; HUMAN; METHODOLOGY; MOLECULAR PROBE; MOLECULAR STABILITY; PHAGE DISPLAY; PROTEIN ANALYSIS; PROTEOMICS; CHEMISTRY; EQUIPMENT; EQUIPMENT DESIGN; EVALUATION; GENETICS; INSTRUMENTATION; METABOLISM; PROTEIN MICROARRAY; SEQUENCE ANALYSIS; VALIDATION STUDY;

ANTIBODIES, MONOCLONAL; EQUIPMENT DESIGN; EQUIPMENT FAILURE ANALYSIS; HUMANS; IMMUNOGLOBULIN FRAGMENTS; PEPTIDE LIBRARY; PROTEIN ARRAY ANALYSIS; PROTEINS; PROTEOMICS; RECOMBINANT PROTEINS; SEQUENCE ANALYSIS, PROTEIN;

EID: 0036908782     PISSN: 07366205     EISSN: None     Source Type: Journal    
DOI: 10.2144/dec02steinhauer     Document Type: Article

References (35)

1. Alizadeh, A.A., M.B. Eisen, R.E. Davis, C. Ma, I.S. Lossos, A. Rosenwald, J.C. Boldrick, H. Sabet, et al. 2000. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403:503-511.
2. Borrebaeck, C.A.K. 2000. Antibodies in diagnostics - From immunoassay to protein chips. Immunol. Today 21:379-382.
3. Borrebaeck, C.A.K., S. Ekström, A.C. Malmborg Hager, J. Nilsson, T. Laurell, and G. Marko-Varga. 2001. Protein chips based on recombinant antibody fragments: A highly sensitive approach as detected by mass spectrometry. BioTechniques 30.1126-1132.
4. Breen, E.D., J.G. Curley, D.E. Overcashier, C.C. Hsu, and S.J. Shire. 2001. Effect of moisture on the stability of a lyophilized humanized monoclonal antibody formulation. Pharm. Res. 18:1345-1353.
5. Buder, J.E. 2000. Solid supports for enzyme-linked immunosorbent assay and other solid-phase immunoassays. Methods 22:4-23.
6. Chothia, C., I. Gelfand, and A. Kister. 1998. Structural determinants in the sequences of immunoglobulin variable domain. J. Mol. Biol. 278:457-479.
7. Connolly, M.L. 1983. Solvent-accessible surfaces of proteins and nucleic acids. Science 221:709-713.
8. Ek, S., C.-M. Högerkorp, M. Dictor, M. Ehinger, and C.A.K. Borrebaeck. 2002. Mande cell lymphomas express a distinct genetic signature affecting lymphocyte trafficking and growth regulation as compared to normal human B cells. Cancer Res. 62:4398-4405.
9. Glynne, R., G. Ghandour, J. Rayner, D.H. Mack, and C.C. Goodnow. 2000. B-lymphocyte quiescence, tolerance and activation as viewed by global gene expression profiling on microarrays. Immunol. Rev. 176:216-246.
10. Golub, T.R., D.K. Slonim, P. Tamayo, C. Huard, M. Gaasenbeek, J.P. Mesirov, H. Coller, M.L. Loh, et al. 1999. Molecular classification of cancer: Class discovery and class prediction by gene expression monitoring. Science 286:531-537.
11. Guex, N. and M.C. Peitsch. 1997. SWISS-MODEL and the Swiss-Pdb Viewer: An environment for comparative protein modeling. Electrophoresis 18:2741-2723.
12. Guruprasad, K., B.V. Reddy, and M.W. Pandit. 1990. Correlation between stability of a protein and its dipeptide composition: A novel approach for predicting in vivo stability of a protein from its primary sequence. Protein Eng. 4:155-161.
13. Haab, B.B. 2001. Advances in protein microarray technology for protein expression and interaction profiling. Curr. Opin. Drug Discov. Devel. 4:116-123.
14. Haab, B.B., M.J. Dunham, and P.O. Brown, 2001. Protein microarrays for highly parallel detection and quantitation of specific proteins and antibodies in complex solutions. Genome Biol. 2:RESEARCH0004.1-13.
15. Ikai, A. 1980. Thermostability and aliphatic index of globular proteins. J. Biochem. 88:1895-1898.
16. Jaenicke, R. 2000. Stability and stabilization of globular proteins in solution. J. Biotechnol. 79:193-203.
17. Joos, T.O., M. Schrenk, P. Hopfl, K. Kroger, U. Chowdhury, D. Stoll, D. Schorner, M. Durr, et al. 2000. A microarray enzyme-linked immunosorbent assay for autoimmune diagnostics. Electrophoresis 21:2641-2650.
18. Jung, S., S. Spinelli, B. Schimmele, A. Honegger, L. Pugliese, C. Cambillau, and A. Plückthun. 2001. The importance of framework residues H6, H7 and H10 in antibody heavy chains: Experimental evidence for a new structural subclassification of antibody VH domains. J. Mol. Biol. 309:701-716.
19. Klein, U., Y. Tu, G.A. Stolovitzky, I.M. Mattiol, G. Cattoretti, H. Husson, A. Freedman, G. Inghirami, et al. 2001. Gene expression profiling of B cell chronic lymphocytic leukemia reveals a homogeneous phenotype related to memory B cells. Exp. Med. 194:1625-1638.
20. Kyte, J. and R.E Doolittle. 1982. A simple method for displaying the hydropathic character of a protein. J. Mol. Biol. 157:105-132.
21. Lai, M.C. and E.M. Topp. 1999. Solid-state chemical stability of proteins and peptides. J. Pharm. Sci. 88:489-500.
22. Lantto, J., Y. Lindroth, and M. Ohlin. 2002. Non-germ-line encoded residues are critical for effective antibody recognition of a poorly immunogenic neutralization epitope on glycoprotein B of human cytomegalovirus. Eur. J. Immunol. 32:1659-1669.
23. Lockhart, D.J. and E.A. Winzeler. Genomics, gene expression and DNA arrays. 2000. Genomics, gene expression and DNA arrays. Nature 405:827-836.
24. MacBeath, G. and S.L. Schreiber. 2000. Printing proteins as microarrays for high-throughput function determination. Science 289:1760-1763.
25. McCafferty, J., A.D. Griffiths, G. Winter, and D.J. Chiswell. 1990. Phage antibodies: Filamentous phage displaying antibody variable domains. Nature 348:552-554.
26. Mitchell, P. 2002. A perspective on protein microarrays. Nat. Biotechnol. 20:225-229.
27. Nicholls, A., K. Sharp, and B. Honig. 1991. Protein folding and association: Insights from the interfacial and thermodynamic properties of hydrocarbons. Proteins 11:281-296.
28. Ohlin, M., H. Owman, J.D. Rioux, M.M. Newkirk, and C.A.K. Borrebaeck. 1994. Restricted variable region gene usage and possible rheumatoid factor relationship among human monoclonal antibodies specific for the AD-1 epitope on cytomegalovirus glycoprotein B. Mol. Immunol. 31:983-991.
29. Spaete, R.R. 1991. A recombinant subunit vaccine approach to HCMV vaccine development. Transplant Proc. 23:90-96.
30. Staudt, L.M. 2001. Gene expression physiology and pathophysiology of the immune system. Trends Immunol. 22:35-40.
31. Söderlind, E., L. Strandberg, P. Jirholt, N. Kobayashi, V. Alexeiva, A.M. Åberg., A. Nilsson, B. Jansson, et al. 2000. Recombining germline-derived CDR sequences for creating diverse single-framework antibody libraries. Nat. Biotechnol. 18:852-856.
32. Webster, D.M., A.H. Henry, and A.R. Rees. 1994. Antibody-antigen interactions. Curr. Opin. Struct. Biol. 4:123-129.
33. Winter, G. and C. Milstein. 1991. Man-made antibodies. Nature 349:293-299.
34. Wörn, A. and A. Pliickthun. 1999. Different equilibrium stability behaviour of scFv fragments: Identification, classification, and improvements by protein engineering. Biochemistry 38:8739-8750.
35. Wörn, A. and A. Plückthun. 2001. Stability engineering of antibody single-chain Fv fragments. J. Mol. Biol. 305:989-1010.